Cargando…

Invasive Nocardia Infections across Distinct Geographic Regions, United States

We reviewed invasive Nocardia infections in 3 noncontiguous geographic areas in the United States during 2011–2018. Among 268 patients with invasive nocardiosis, 48.2% were from Minnesota, 32.4% from Arizona, and 19.4% from Florida. Predominant species were N. nova complex in Minnesota (33.4%), N. c...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Simran, Grant, Leah M., Powers, Harry R., Kimes, Kathryn E., Hamdi, Ahmed, Butterfield, Richard J., Gea-Banacloche, Juan, Vijayvargiya, Prakhar, Hata, D. Jane, Meza Villegas, Diana M., Dumitrascu, Adrian C., Harris, Dana M., Chirila, Razvan M., Zhang, Nan, Razonable, Raymund R., Kusne, Shimon, Alvarez, Salvador, Vikram, Holenarasipur R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683819/
https://www.ncbi.nlm.nih.gov/pubmed/37987603
http://dx.doi.org/10.3201/eid2912.230673
Descripción
Sumario:We reviewed invasive Nocardia infections in 3 noncontiguous geographic areas in the United States during 2011–2018. Among 268 patients with invasive nocardiosis, 48.2% were from Minnesota, 32.4% from Arizona, and 19.4% from Florida. Predominant species were N. nova complex in Minnesota (33.4%), N. cyriacigeorgica in Arizona (41.4%), and N. brasiliensis in Florida (17.3%). Transplant recipients accounted for 82/268 (30.6%) patients overall: 14 (10.9%) in Minnesota, 35 (40.2%) in Arizona, and 33 (63.5%) in Florida. Manifestations included isolated pulmonary nocardiosis among 73.2% of transplant and 84.4% of non–transplant patients and central nervous system involvement among 12.2% of transplant and 3.2% of non–transplant patients. N. farcinica (20.7%) and N. cyriacigeorgica (19.5%) were the most common isolates among transplant recipients and N. cyriacigeorgica (38.0%), N. nova complex (23.7%), and N. farcinica (16.1%) among non–transplant patients. Overall antimicrobial susceptibilities were similar across the 3 study sites.